je.st
news
Home
› Premarket Biotech Digest: Valeant's M&A Prospects, Stocks Tumble, Novartis Promacta Extension
Premarket Biotech Digest: Valeant's M&A Prospects, Stocks Tumble, Novartis Promacta Extension
2015-08-25 23:15:17| Biotech - Topix.net
The iShares NASDAQ Biotechnology Index ETF fell another 4% on Monday and is now down more than 11% in the last three trading sessions amid a selloff in the broader market. Not surprisingly, the question every biotech focused investor is asking right now is whether this is an opportunity to buy.
Tags: extension
stocks
prospects
digest
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||